Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.755 USD | -1.70% |
|
-6.20% | +42.64% |
08/05 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Analyst Reco.